Corbus Pharmaceuticals Holdings, Inc. (CRBP)
11.24
-0.22
(-1.92%)
USD |
NASDAQ |
Sep 04, 12:52
Corbus Pharmaceuticals Holdings Price to Book Value : 2.053 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 03, 2026 | 2.093 |
| September 02, 2026 | 2.096 |
| September 01, 2026 | 2.06 |
| August 31, 2026 | 1.992 |
| August 28, 2026 | 1.992 |
| August 27, 2026 | 2.033 |
| August 26, 2026 | 2.064 |
| August 25, 2026 | 2.066 |
| August 24, 2026 | 1.952 |
| August 21, 2026 | 1.896 |
| August 20, 2026 | 1.797 |
| August 19, 2026 | 1.824 |
| August 18, 2026 | 1.841 |
| August 17, 2026 | 1.916 |
| August 14, 2026 | 1.843 |
| August 13, 2026 | 1.841 |
| August 12, 2026 | 1.782 |
| August 11, 2026 | 1.737 |
| August 10, 2026 | 1.728 |
| August 07, 2026 | 1.857 |
| August 06, 2026 | 1.779 |
| August 05, 2026 | 1.748 |
| August 04, 2026 | 1.717 |
| August 03, 2026 | 1.629 |
| July 31, 2026 | 1.638 |
| Date | Value |
|---|---|
| July 30, 2026 | 1.653 |
| July 29, 2026 | 1.629 |
| July 28, 2026 | 1.659 |
| July 27, 2026 | 1.658 |
| July 24, 2026 | 1.675 |
| July 23, 2026 | 1.702 |
| July 22, 2026 | 1.614 |
| July 21, 2026 | 1.64 |
| July 20, 2026 | 1.624 |
| July 17, 2026 | 1.645 |
| July 16, 2026 | 1.607 |
| July 15, 2026 | 1.645 |
| July 14, 2026 | 1.649 |
| July 13, 2026 | 1.651 |
| July 10, 2026 | 1.768 |
| July 09, 2026 | 1.764 |
| July 08, 2026 | 1.744 |
| July 07, 2026 | 1.713 |
| July 06, 2026 | 1.644 |
| July 02, 2026 | 1.689 |
| July 01, 2026 | 1.656 |
| June 30, 2026 | 1.713 |
| June 29, 2026 | 1.261 |
| June 26, 2026 | 1.227 |
| June 25, 2026 | 1.158 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.689 |
| Alnylam Pharmaceuticals, Inc. | 26.22 |
| Anika Therapeutics, Inc. | 2.043 |
| Savara, Inc. | 7.635 |
| Vericel Corp. | 5.567 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0614 |
| Price | 11.24 |
| Earnings Yield | -54.95% |
| Market Cap | 209.87M |
| PEGY Ratio | -0.0614 |